BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3818134)

  • 1. The 5-hydroxytryptamine system of blood platelets: physiology and pathophysiology.
    Pletscher A
    Int J Cardiol; 1987 Feb; 14(2):177-88. PubMed ID: 3818134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca2+ as messenger of 5HT2-receptor stimulation in human blood platelets.
    Affolter H; Erne P; Bürgisser E; Pletscher A
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):337-42. PubMed ID: 6427633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization and resensitization of human platelets to 5-hydroxytryptamine at the level of signal transduction.
    Roevens P; de Chaffoy de Courcelles D
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):775-82. PubMed ID: 7741708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood platelets as models for central 5-hydroxytryptaminergic neurons.
    Pletscher A; Laubscher A; Graf M; Saner A
    Ann Biol Clin (Paris); 1979; 37(1):35-9. PubMed ID: 443611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
    Bevan J; Heptinstall S
    Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
    Amstein R; Fetkovska N; Bühler FR
    J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
    Amstein R; Fetkovska N; Pletscher A; Bühler FR
    J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice.
    Yu Z; Ohba M; Nakamura M; Sasano T; Ono M; Sugawara S; Endo Y
    Thromb Haemost; 2009 Dec; 102(6):1251-8. PubMed ID: 19967158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urapidil inhibits 5-hydroxytryptamine induced platelet aggregation and 14C-5-hydroxytryptamine uptake in platelets.
    Storck J; Kirsten R
    Curr Med Res Opin; 1990; 12(2):86-92. PubMed ID: 2390867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of mechanisms of amine storage in the dense bodies of human platelets.
    Costa JL; Eanes ED
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):347-66. PubMed ID: 6095385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human platelet 5HT receptors: characterisation and functional association.
    Peters JR; Grahame-Smith DG
    Eur J Pharmacol; 1980 Dec; 68(3):243-56. PubMed ID: 7202490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels.
    Mercado CP; Kilic F
    Mol Interv; 2010 Aug; 10(4):231-41. PubMed ID: 20729489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal serotonin uptake by blood platelets and brain synaptosomes but selective impairment of platelet serotonin storage in mice with Chediack-Higashi syndrome.
    Lampugnani MG; Buczko W; Ceci A; Mennini A; de Gaetano G
    Life Sci; 1986 Jun; 38(24):2193-8. PubMed ID: 3713444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells.
    Aune TM; Kelley KA; Ranges GE; Bombara MP
    J Immunol; 1990 Sep; 145(6):1826-31. PubMed ID: 2144010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine kinetics and activation of blood platelets in patients with essential hypertension.
    Fetkovska N; Amstein R; Ferracin F; Regenass M; Bühler FR; Pletscher A
    Hypertension; 1990 Mar; 15(3):267-73. PubMed ID: 2137432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Clin Physiol Biochem; 1990; 8 Suppl 3():1-18. PubMed ID: 2132170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma serotonin levels and the platelet serotonin transporter.
    Brenner B; Harney JT; Ahmed BA; Jeffus BC; Unal R; Mehta JL; Kilic F
    J Neurochem; 2007 Jul; 102(1):206-15. PubMed ID: 17506858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.
    Fetkovska N; Pletscher A; Ferracin F; Amstein R; Buhler FR
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():105-9. PubMed ID: 1704794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
    Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
    Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5HT2 receptor-mediated function in depressed patients: investigation by measuring 5HT-induced shape change of blood platelets.
    Kaneko M; Mashiko H; Yagiuchi T; Ohsuka N; Kumashiro H
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):169-74. PubMed ID: 1635306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.